Business Wire

Landmark Celebrates 30 Years as the Industry Leader in Personal & Professional Growth, Training and Development

Share

Landmark (Landmark Worldwide), established in 1991, celebrates its 30th anniversary with more than three million people across the globe having been positively and powerfully contributed to and empowered by its programs. Marking a related anniversary, it was 50 years ago that the ideas that grew into Landmark were born with the delivery of the first est Training in 1971.

As the leader in the personal and professional growth, training and development industry, Landmark’s programs and ideas have empowered people for five decades to dramatically elevate the quality of their lives and, in addition, to impact the areas of their lives that matter most to them.

Marketdata Enterprises, Inc., publishers of the definitive report on the personal development industry in the United States, stated in their 2021 report:

  • “Landmark was named one of the top training and development companies in the world by HR.com/James McNeil.”
  • “Landmark is recognized for having one of the best faculty bodies in the business,” and many professionals “in the personal development and coaching industries got their start by participating in Landmark’s programs.”
  • Landmark is unique in the industry as the “sole program provider of ontological transformation … a transformation in being – a breakthrough that results in immediate, lasting, and dramatic shifts in people’s effectiveness and quality of life.”

50 years ago, Werner Erhard’s est Training launched the personal development industry and the beginning of what has since become the business and life coaching industry. Many of his concepts have earned a lasting place in mainstream culture, business and academia. As TIME magazine recognized, “The American obsession with transformation isn’t new. It’s about as old as the nation, but it was Werner Erhard ... who created the first modern transformation when he founded est seminars in 1971.”

Erhard retired the est Training and launched a new course, The Forum, in 1985. Erhard’s ideas (as expressed in his programs) are examined in detail by two scholars in the best-selling book, Speaking Being: Werner Erhard, Martin Heidegger, and a New Possibility of Being Human.

Described as “one of the most incisive and insightful thinkers of our generation" by David Eagleman, Ph.D., Stanford University neuroscientist and New York Times bestselling author, Erhard has committed the majority of his intellectual efforts over the past three decades to the academic world. With his colleagues, he is writing university-level curricula and teaching and lecturing at universities including the UCLA Anderson School of Management, the United States Air Force Academy, Stanford University, Harvard University, Yale University, Dartmouth College, and Erasmus University.

Today, Landmark continues to make its programs available throughout the world, including having launched virtually all of its more than 50 programs online. Landmark has been and continues to be endorsed by thousands of renowned leaders worldwide, including CEOs of global corporations, widely respected academics, and internationally recognized humanitarians.

“What greatly impressed me with regard to Landmark is it gives people a hands-on access to altering the culture of an organization and to effect significant change in a surprisingly short period of time.”

~ Michael C. Jensen, Jesse Isidor Straus Professor of Business Administration, Emeritus at Harvard University

“Winning a gold medal at the Olympics was extraordinary and, when I did The Landmark Forum, I realized I could have that same level of accomplishment, fulfillment, and joy in every part of my life.”

~ Natalie Cook, Olympic Gold Medalist

“As a person whose life is about global issues, I can’t think of a more effective training program. One of the most valuable results I got was the ability to deal with intractable global problems without getting discouraged. As a result of participating in Landmark, individuals gain the tools to go out into the world and make things happen.”

~ Dr. Charles McNeill, Senior Policy Advisor, United Nations Environment Programme

“I have yet to see anything else that has such a positive impact on people’s ability to relate, communicate, and perform as Landmark.”

~ Paul Fireman, Founder and former Chairman/CEO of Reebok International, Ltd. USA

Landmark’s global management consulting firm and subsidiary, Vanto Group was named one of America’s Best Management Consulting Firms by Forbes Magazine for two consecutive years – 2020 and 2021. In addition, Landmark is the primary catalyst for participants creating more than 150,000 non-profit and pro bono projects, benefiting individuals, organizations, and communities around the world. A few examples include:

  • Special Spectators (for which founder, Blake Rockwell was named a CNN Hero) has had a significant impact on tens of thousands of seriously ill children, their siblings and parents by giving them a VIP access game day experience at more than 50 major colleges and universities.
  • Plant a Million Trees: Gashaw Tahir founded an NGO called Greenland Development Foundation that planted more than a million trees in Ethiopia and, in the process, put more than 450 young people to work, giving them not only a sense of dignity, but the ability to see a future in Ethiopia.
  • R U OK? Day: A suicide prevention project that has been embraced by the entire country of Australia.

Landmark acknowledges and thanks the more than three million people who have participated in its work and the difference they make in their own lives, in the lives of others, and throughout the world.

For more information about Landmark and its programs, visit www.landmarkworldwide.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Michelle Tennant Nicholson at Wasabi Publicity Inc.
+1-828-749-3200
Michelle@WasabiPublicity.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release

Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single

Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release

Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release

Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap

DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press Release

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press Release

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye